Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study ; day:15 ; month:04 ; year:2024
South Asian journal of cancer ; (15.04.2024)
- Beteiligte Personen und Organisationen
-
Simhadri, Soumya
Dayyala, Sowmya
Musinipally, Anjani Devi
Guram, Lavanya
Madavi, Mamatha
Kancha, Ramakrishna
Puligundla, Krishna Chaitanya
- DOI
-
10.1055/s-0044-1786001
- URN
-
urn:nbn:de:101:1-2406061102323.947049836804
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Simhadri, Soumya
- Dayyala, Sowmya
- Musinipally, Anjani Devi
- Guram, Lavanya
- Madavi, Mamatha
- Kancha, Ramakrishna
- Puligundla, Krishna Chaitanya
Ähnliche Objekte (12)
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction